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An increasing aging population greatly impacts health care services worldwide. A large
percentage of healthcare expenditures for seniors arise from the negative outcomes of
muscle loss, also known as sarcopenia. Aging-related losses of muscle strength and quality
impair balance, walking ability and endurance and cause negative events such as falls,
incident disability and frailty. This review systemically explores the significance of sar-
copenia in the elderly and addresses several important physiological mechanisms of sar-
copenia. The implications of crucial exercise regimens that improve muscle strength and
delay the onset of sarcopenia are also discussed.
Copyright © 2015, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).A rapidly expanding aging population is one of the factors that
impacts health care services across the globe. According to
statistics from the U.S. Bureau of the Census, the number of
people who are 65 years or older (seniors) equaled 43.1 million
in July 2012, representing 15% of the U.S. population. By 2050,
it is projected that there will be about 83.7 million seniors
representing almost 20% of the population [1]. Health care
expenditures for seniors in the U.S. are expected to increase
six-fold by 2040 [2] and a high percentage of health care costs
for seniors arise from the negative outcomes of lean muscle
mass loss [3].
This review explores the impact of sarcopenia, which re-
fers to the loss of muscle mass and the decline of muscle
quality with increased age [4], on the mobility and indepen-
dence of the elderly. The physiological causes of sarcopenia
and the implications of exercise regimens to improve muscle
strength or to delay sarcopenia are discussed.Nursing Association.
g Association. Production
://creativecommons.org/1. Significance of sarcopenia
The term of “sarcopenia” was first introduced in 1989 to
describe a progressive, generalized loss of skeletal muscle
mass and accompanying decline in muscle strength and per-
formance with increasing age. Sarcopenia is associated with
many negative outcomes, such as disability, frailty, comor-
bidities, hospital admissions and death [4e6].
The prevalence of sarcopenia with advanced age has been
well-documented. Baumgartner and colleagues [7] utilized
data from a population-based study and analyzed the epide-
miology of sarcopenia among the New Mexico elderly. The
prevalence of sarcopenia was 13e14% in persons under age 70
and >50% in those older than 80. In a 7.8 year longitudinal
study, Forbes and Reina [8] reported an average loss of 0.25 kg/
year of lean muscle mass among the participants aged 22e53.and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
licenses/by-nc-nd/4.0/).
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well-recognized. Roubenoff [9] investigated the close rela-
tionship between muscle mass and strength and found that
sarcopenia was important in functional deterioration,
including declines in gait and balance, increased fall risks, and
loss of independence [10]. Murphy and colleagues [11] exam-
ined the time-course of sarcopenia determinants and found
that low functioning, lack of physical activity and a high body
mass indexpredicted transition toward sarcopenia,whichwas
more likely to lead to death. Szulc and associates [12] assessed
the degree of sarcopenia by the relative appendicular skeletal
muscle (RASM)mass index. They found that a decreasedRASM
value among elderlymenwas associatedwith a lower bending
strength. Therefore, the authors concluded that sarcopenia in
older men was associated with impaired balance and an
increased risk of falling. The relationship between sarcopenia
and functional status was also investigated in the NewMexico
Study7, which revealed that people with sarcopenia had 3e4
fold higher rates of disability, significantly greater risks of
falling, andweremore likely to use assistive devices [7]. Metter
et al. [13] found that sarcopenia could act as a significant pre-
dictor of all-cause mortality.
The loss of muscle mass and quality also has metabolic
and physiological consequences. Sarcopenia may influence
the body's thermoregulation process in both cold and warm
environments [14] and may contribute to age-associated
glucose intolerance [15].
Therefore, sarcopenia not only has detrimental effects on
physical functioning, but also impacts skeletal and metabolic
health. Sarcopenia greatly diminishes the overall quality of
life [3].2. Etiology of sarcopenia
Sarcopenia, likemany other problems that occurwith aging, is
a multifactorial condition. Factors that contribute to the
occurrence of sarcopenia in the elderly include motor units,
protein metabolism, hormones and lifestyle [9].
2.1. Motor units
The loss of alphamotor units from the spinal cord is thought to
be themost crucial contributor to sarcopenia [9]. Many studies
support this idea. Yuan et al. [16] found from direct micro-
scopic observation that the number of motor neurons in the
spinal cord decreased with aging. Similarly, McNeil and col-
leagues [17] found differences in the number of motor units in
the tibialis anterior of young and older men. Their results
indicate that age-related motor unit loss may contribute to
sarcopenia, but seldom limitsmobility or independence until a
critical threshold is reached. Concomitant with the decreased
number of motor units, the increased size of the remaining
motor units and the loss of muscle fibers have also been
identified as significant contributing factors to sarcopenia [18].
2.2. Protein metabolism
The balance between protein break down and synthesis rates
is crucial in maintaining muscle mass and studies show thatthere is a direct relationship between sarcopenia and changes
in muscle metabolism. Balagopal et al. [19] found that mixed
muscle protein synthesis was reduced by 30% with advanced
age. However, the reduction of muscle protein synthesis
appeared to be selective. Specifically, whereas synthesis rates
of mixedmuscle proteins andmyosin heavy chains decreased
by more than 40% in the elderly; sarcoplasmic protein syn-
thesis rates were maintained or increased with age. Several
studies have investigated this selectivity, suggesting [20] that
it might be due to decreased number sof messenger ribonu-
cleic acid (mRNA) for protein translation. Therefore, it is quite
likely that the selective decrease in protein synthesis plays an
important role in the development of sarcopenia.
2.3. Hormone factors
Many hormones have metabolic effects on muscle mass and
function. A convincing body of evidence indicates that the
aging process alters the circulating concentrations of several
important muscle-building hormones [3]. For brevity, this re-
view will concentrate on two important anabolic hormones:
testosterone and growth hormone (GH).
2.3.1. Testosterone
Multiple studies indicate that the level of bioavailable free
testosterone decreases with age [21]. Specifically, free testos-
terone levels decrease approximately 3% per year between the
ages of 73 and 94 [22]. Additionally, studies show that aging
decreases the sensitivity of target tissues, such as muscle, to
testosterone [23]. Clinical studies indicate that among the
elderly both the decreased level of testosterone and the
insensitivity of muscle tissues to testosterone contribute to
sarcopenia [24].
2.3.2. Growth hormone (GH)
SinceGH is important inmusclemassgrowthandmaintenance,
this hormone has been given much attention in recent sarco-
penia studies.Multiple studies found that the level of circulating
GH decreases with age. For example, Veldhuis and colleagues
[25] found that most of their study participants' GH levels
declined by approximately 50% between the ages of 20 and 70.
Somestudieshaveshowna linkbetween thedecliningGH levels
and the loss of muscle mass in the elderly [26]. However, the
specific roleof thedecreasedGH levels in sarcopeniaoccurrence
and the feasibility of GH supplementation in sarcopenia man-
agement are still unclear and need further investigation.
2.4. Lifestyle factors
It has been well-documented that physical inactivity and mus-
cle disuse promote the loss of muscle mass and worsen the
degree of sarcopenia [9]. Studies also show that the decline in
food intake and protein consumption among the elderly
contribute tomuscle atrophyand the severity of sarcopenia [21].3. Exercise management and implications
Progressive resistance training has long been identified as the
most promising imethod for increasing muscle mass and
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confirmed the effectiveness of resistance training in
improving muscle mass, strength, balance and endurance
among the elderly. For example, Yarasheski and colleagues
[29] found that resistance training could enormously enhance
the rate of mixed muscle protein synthesis in physically frail
older participants. After three months of weight-lifting exer-
cise, the muscle contractile protein synthesis rates in these
sedentary seniors were greatly increased. In a randomized
and placebo-controlled trial, including nursing home resi-
dents, ten weeks of progressive resistance training increased
muscle cross sectional area by 3e9% and improved muscle
strength and performance in gait speed and stair climbing
abilities [30]. Frontera et al. [31] demonstrated that 2 weeks of
progressive resistance training could substantially promote
extensor and flexor strength in older participants. In evalu-
atingmuscle protein breakdown during sarcopenia and aging,
Fry and associates [32] found that regulators ofmuscle protein
breakdown responded similarly in young and older adults
following resistance training, suggesting that resistance
training could slow the pace of sarcopenia. Therefore, it is
reasonable to conclude from these studues that progressive
resistance training could effectively improve or prevent sar-
copenia among the elderly, via improvements in muscle mass
and strength.
3.1. Implications for exercise prescriptions
When designing a resistance exercise program to manage
sarcopenia, some specific guidelines should be addressed. The
goal is to gradually overload the muscles and make positive
adaptations, such as improvement in muscle mass and
function [33]. At the same time, sufficient attention should be
paid to specific and normal aging-related physiological in
order to avoid exercise-related injuries or severe outcomes.
Generally speaking, a progressive resistance training pro-
gram for sarcopenia should be dynamic and target the major
muscle groups using both concentric and eccentric move-
ments [33]. Exercise program that target lower extremity
muscles, such as the knee and hip extensors, should be
prioritized because they are important in mobility, balance
and gait.
3.1.1. Warm-up and cool-down
Warm-up and cool-down periods should be longer for the
elderly [34]. Optimal warm-up activities should last 15e20
minutes, whereas 10e15 minutes should be devoted to the
cool-down period. Active muscles should be stretched in both
periods, and the warm-up session should involve lifting light
weights [35].
3.1.2. Intensity
The intensity of the exercises should be based a combination
of parameters, such as the individual's heart rate and energy
expenditure [34]. When performing resistance training, the
seniors should move the resistance through the entire range
of motion and avoid heavy lifting [35]. Specifically, the
American College of Sport Medicine (ACMS) [36] recommends
resistance training of 65%e75% maximum to increase muscle
strength.3.1.3. Frequency
The guidelines published by ACMS are appropriate to be used
among the elderly.
<3 Metabolic Equivalent (MET): 5 minutes of exercise
several times daily
3e5 METs: at least twice a day as tolerated
5 METs: 3 times a week on alternate days
ACMS [36] recommends that seniors perform resistance
training 2e4 days per week. Hence, the average frequency
should be 3 days per week and the individual should wait at
least 48 hours between training sessions.
3.1.4. Duration
ACMS [36] recommends that seniors dedicate 20e45 minutes
for each resistance training session.
3.1.5. Rest periods and physical environments
Longer rest periods between exercise sessions as well as safe
physical environments are imperative for seniors [34].
3.1.6. Breathing
Seniors should not hold their breath during resistance
training. Lifting belts and abdominal strengthening exercise
may be used to help stabilize the torso in order to facilitate
breathing [35].
3.1.7. Active muscles
Exercise programs that target knee and hip extension and
flexion should both be performed on a regular basis [35].
Antagonistic muscles should also be exercised to keep bal-
ance. ACMS [36] recommends including all six major muscle
groups (chest, shoulders, arms, back, abdomen and legs) into a
comprehensive resistance training programs.
Several studies have elucidated additional details of an
optimal resistance training program. Taaffe [33] suggests that
8e12 repetitions should be performed per set. When the in-
dividual is able to perform 12 repetitions, the resistance
should be increased to a point where only 8 repetitions are
possible. A minimum of one set, but preferably 2e3 sets, per
exercise session is appropriate with 1e2 minutes of rest be-
tween each set. The author also recommends exercising 1e3
days per week, for no more than one hour per session and
with at least 48 hours between sessions.
3.2. Implications and application into daily clinical
practice
Physical frailty in the elderly, especially the impairment in
lower extremity strength, has been widely described in the
geriatric literature as declining physiological conditions and
has been used to screen and identify high-risk individuals for
adverse health events [37]. Physical frailty has also been
recognized as an indicator for fall events in the elderly. The
significant impact of falls has been well-documented. The
elderly who fall increase healthcare costs and patients/family
members may also experience emotional challenges. There-
fore, physical frailty needs to be addressed to prevent or
minimize the occurrence of falls in the elderly.
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nized as a contributing factor to physical frailty. Many studies
have found an association between physical frailty and sar-
copenia. In fact, sarcopenia and physical frailty have been
regarded as two sides of the same coin [38]. They can overlap
and contribute to physical function impairment, such as slow
gait speed or poor balance. Sarcopenia and physical frailty can
also affect each other, greatly impacting critical physiological
parameters. Recent studies conducted in elderly trauma pa-
tients further confirmed that sarcopenia and frailty work
hand-in-hand in critical discharge disposition parameters,
e.g. skilled-nursing facility, nursing home, rehabilitation,
home and home health [39].
Therefore, seniors should perform progressive resistance
exercise training to delay or prevent the development of
physical frailty and its significant negative health conse-
quences. Clinicians can adopt the guidelines from ACMS to
design elderly-tailored progressive and rigorous resistance
training programs to delay sarcopenia and therefore improve
the quality of life for seniors.4. Conclusion
Sarcopenia, the loss of muscle mass and strength, has a
crucial negative impact on seniors' physical functioning, in-
dependence and quality of life. Some biological and lifestyle
factors that occur during aging, such as the decreased number
of motor units, lower mixed protein synthesis rates and al-
terations in circulating hormones, contribute to the occur-
rence of sarcopenia among the elderly. Progressive resistance
training involvingmajormuscles is a simple and effective way
to counteract sarcopenia.
Some important implications for clinical elder care can be
drawn from this review. First of all, geriatric care staff should
be knowledgeable about sarcopenia and its tremendously
detrimental effects. Strategies should be implemented in a
timelymanner to delay the process of sarcopenia or to prevent
severe negative outcomes. Secondly, as resistance training
plays a significant role in sarcopeniamanagement, seniors are
strongly encourage to encourage in moderate resistance ex-
ercise, or at least keep physically active. It is vital for geriatric
professionals to follow exercise guidelines when advising
exercise modalities in order to maximize the exercise benefits
and effectively address the severe outcomes of sarcopenia.r e f e r e n c e s
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